HedgeChatter

  • Home /
  • Tag Archives

MGNX

MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting

[GlobeNewswire] – ROCKVILLE, Md. — MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and … moreView todays social media effects on MGNXView the latest stocks trending across Twitter. Click to view dashboardSee who MacroGenics is hiring next, click here to view […]

April 6, 2014 Bystocknews , Comments Off on MacroGenics Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 at the AACR Annual Meeting read more

MacroGenics to Present at the 26th Annual ROTH Conference

[GlobeNewswire] – ROCKVILLE, Md. — MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and … moreView todays social media effects on MGNXView the latest stocks trending across Twitter. Click to view dashboardSee who MacroGenics is hiring next, click here to view […]

March 3, 2014 Bystocknews , Comments Off on MacroGenics to Present at the 26th Annual ROTH Conference read more

MacroGenics 3M share Secondary priced at $36.50

moreView todays social media effects on MGNXView the latest stocks trending across Twitter. Click to view dashboardSee who MacroGenics is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on MacroGenics 3M share Secondary priced at $36.50 read more

1:53 am MacroGenicss prices 3 mln shares of common stock at $36.50; 1.8 mln shares by co and 1.2 mln shares by selling shareholders

moreView todays social media effects on MGNXView the latest stocks trending across Twitter. Click to view dashboardSee who MacroGenics is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on 1:53 am MacroGenicss prices 3 mln shares of common stock at $36.50; 1.8 mln shares by co and 1.2 mln shares by selling shareholders read more

MacroGenics Announces Pricing of Public Offering of Common Stock

[GlobeNewswire] – ROCKVILLE, Md. — MacroGenics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and identifying innovative monoclonal antibody-based therapeutics for the treatment of cancer and … moreView todays social media effects on MGNXView the latest stocks trending across Twitter. Click to view dashboardSee who MacroGenics is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on MacroGenics Announces Pricing of Public Offering of Common Stock read more